Orchard Therapeutics

Current Openings : 6

Become a Member

Click on Login if you are already member.

Register Login
Current Jobs in Orchard Therapeutics
Jobs 6
Apply Now
19 Jan 2026

Location: London, UK (Laboratory based role) Reporting to: Principal Scientist, Global Technical Development Job Summary Reporting to the Principal Scientist, Global Technical Development, the Scientist I will independently perform laboratory based activities supporting lentiviral vector (LVV) process development. The role…

Apply Now
21 Jan 2026

Location: London, UK (Laboratory based role) Reporting to: Principal Scientist, Global Technical Development Job Summary Reporting to the Principal Scientist, Global Technical Development, the Associate Scientist will contribute towards laboratory based activities supporting lentiviral vector (LVV) process development. Under supervision,…

Apply Now
27 Nov 2025

Location: London, UK Reporting to: Director, Clinical Development Job Summary Orchard Therapeutics is a global biotechnology gene therapy company dedicated to transforming the lives of people affected by rare diseases through the development of innovative cell and gene therapies. Orchard…

Apply Now
06 Nov 2025

Location: London, UK Reporting to: Scientist II, Global Technical Development Job Summary Orchard Therapeutics, a Kyowa Kirin company, is a global gene therapy leader focused on transforming the life of patients with rare disorders through innovative gene therapies based on…

Apply Now
06 Nov 2025

Location: London Reporting to: Vice President, Global Quality Job Summary Reporting to the Vice President, Global Quality, the Director, GCP, GVP, & GLP QA is a key leadership role responsible for establishing and executing the strategy for GCP, GVP, &…

Apply Now
05 Nov 2025

Location: London, UK Reporting to: Head of Regulatory Operations Job Summary Orchard Therapeutics is a leading global fully integrated commercial and clinical stage company dedicated to transforming the lives of patients with rare diseases through innovative gene therapies. We are…